Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

FDA On Legal Tightrope In Push To Restrict Drug Ads No Photo Available

Dan McKay

The U.S. Food and Drug Administration helped unleash a flood of "direct to consumer" drug advertisements in the 1990s. Copious First A... (more story)

Oregon Joins Expansion Of '5NP' Acupuncture Practice No Photo Available

Gianna Ferrarin

Oregon has joined a number of states that have enacted laws that make it easier for people to get a "five needle" therapy with a raft ... (more story)

The Limits On Blue States' Push For Vaccine Policy Control No Photo Available

Yeji Jesse Lee

Democratic-run states are changing vaccine policies as HHS Secretary Robert F. Kennedy Jr. and other Trump health officials move to re... (more story)